文献速递肥胖与代谢综合征

新型MC4R-F313Sfs*29功能缺失突变与重度肥胖

A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

在209例BMI≥35 kg/m2的不相关肥胖患者中筛查MC4R基因,发现一名BMI 38.8 kg/m2的年轻男孩携带新型杂合突变MC4R-F313Sfs*29。体外实验显示该突变使HEK293细胞在激动剂刺激后cAMP和Ca2+水平不升高(∆R/R0 = -90% ± 8%;P < 0.001),提示其可能通过损害α-MSH诱导的G蛋白信号转导导致饱腹信号失调和早发肥胖。

要点

  • MC4R-F313Sfs*29是209例肥胖患者中唯一发现的变异。
  • 该突变导致cAMP和Ca2+信号几乎完全丧失(∆R/R0 = -90% ± 8%)。
  • 突变可能引起饱腹信号失调,导致贪食和早发肥胖。

核心结论

  • 新发现的MC4R-F313Sfs*29变异可能损害α-MSH诱导的cAMP和Ca2+信号,钝化G蛋白介导的信号转导。
  • 该改变可能导致饱腹信号失调,引起贪食和早发肥胖。

研究设计与样本

  • 在209例不相关肥胖患者(BMI ≥ 35 kg/m2)中进行MC4R基因突变筛查。
  • 对F313Sfs*29突变型MC4R进行计算结构建模和体外功能研究,使用转染了cAMP和Ca2+生物传感器的HEK293细胞。

主要发现

  • F313Sfs*29是唯一鉴定出的变异,发现于一例BMI 38.8 kg/m2的年轻男孩。
  • 体外实验中,转染突变型MC4R的HEK293细胞在特异性激动剂刺激后细胞内cAMP或Ca2+水平不增加,与野生型相比∆R/R0 = -90% ± 8%(P < 0.001)。
  • 计算机建模显示F313Sfs*29突变引起MC4R胞质结构域重大重排,降低推定的GαS结合位点亲和力。

临床怎么用

  • 对早发重度肥胖患者可考虑MC4R基因筛查以识别潜在致病性变异。
  • 检出MC4R功能缺失变异有助于理解贪食和饱腹信号失调的病理机制。

局限性

  • 研究仅在一例患者中鉴定出该变异,未报告家系共分离数据。
  • 功能研究仅在HEK293细胞中进行,未在生理相关细胞或模型中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Melanocortin receptor-4 (MC4R) gene mutations are associated with early-onset severe obesity, and the identification of potential pathological variants is crucial for the clinical management of patients with obesity. OBJECTIVE: To explore whether and how a novel heterozygous MC4R variant (MC4R-F313Sfs*29), identified in a young boy (body mass index [BMI] 38.8 kg/m2) during a mutation analysis conducted in a cohort of patients with obesity, plays a determinant pathophysiological role in the obesity development. DESIGN SETTING AND PATIENTS: The genetic screening was carried out in a total of 209 unrelated patients with obesity (BMI ≥ 35 kg/m2). Structural and functional characterization of the F313Sfs*29-mutated MC4R was performed using computational approaches and in vitro, using HEK293 cells transfected with genetically encoded biosensors for cAMP and Ca2+. RESULTS: The F313Sfs*29 was the only variant identified. In vitro experiments showed that HEK293 cells transfected with the mutated form of MC4R did not increase intracellular cAMP or Ca2+ levels after stimulation with a specific agonist in comparison with HEK293 cells transfected with the wild type form of MC4R (∆R/R0 = -90% ± 8%; P < 0.001). In silico modeling showed that the F313Sfs*29 mutation causes a major reorganization in the cytosolic domain of MC4R, thus reducing the affinity of the putative GalphaS binding site. CONCLUSIONS: The newly discovered F313Sfs*29 variant of MC4R may be involved in the impairment of α-MSH-induced cAMP and Ca2+ signaling, blunting intracellular G protein-mediated signal transduction. This alteration might have led to the dysregulation of satiety signaling, resulting in hyperphagia and early onset of obesity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Trevellin E, Granzotto M, Host C, et al. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity. J Clin Endocrinol Metab. 2021. PMID: 33247923. doi:10.1210/clinem/dgaa885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。